What Is a Cancer Clinical Trials?
A cancer clinical trials is a medical research study in which people participate as volunteers to test new methods of prevention, screening, diagnosis, or treatment of a disease. A cancer clinical trial can also be referred to as a cancer clinical study.
Some cancer patients receiving chemotherapy could get anemia, and this disease
is treat in clinical research. Chemo induced anemia study may receive the best and more effective cancer treatment by clinical trials.
What are the Phases of a Cancer Clinical Trial?
Clinical cancer research are usually conducted in a series of steps, called “phases.” Each clinical trial phase is designed to answer a separate research question.
- Phase I: Trials evaluate safety.
- Phase II: Trials measure effectiveness.
- Phase III: Trials test against best existing cancer treatment.
- Phase IV: Trials are conducted to further evaluate new uses or long-term effects of the treatment.
What is a Randomized Cancer Clinical Trial?
Cancer clinical trial is a study in which the participants are assigned by chance to separate groups to compare different cancer treatments; neither the researchers nor the participants choose which group the patient is entered into. People are assigned by chance to either a standard treatment group or investigatory treatment arm. In cancer clinical trials the control group invariably receives the standard treatment currently available.
Is a Drugs used at Cancer Clinical Trials under Investigation?
First of all the new medicine is under investigation before be testing in people as volunteers conditions, but has not yet been approved for Food and Drug Administration (FDA) by proving to be safe and effective for the treatment in this specific case of chemo induced anemia. A drug may be approved by the FDA for use in one disease or condition, but be considered investigation in other uses.
Is Cancer Clinical Trials Important?
Yes, the cancer clinical trials are very important, when people with cancer participate in a clinical trials, they are treating a new medicine that can help miles of person under the same disease. The patients are followed more closely by their doctors and nurses. This monitoring is an integral part of the cancer clinical trial process, and undoubtedly provides cancer patients with a high quality experience, whether they are in the treatment or control group.